All PlansCoverageLow impact
Newsletter Vol. 2, No. 23
New Jersey Medicaid·NJ·Pharmacy
We identified it
Jun 20, 2026
Summary
This policy update addresses Drug Efficacy Study Implementation (DESI) requirements for drug products that lack substantial evidence of effectiveness. The policy appears to be pharmacy-related and may affect billing for certain medications or drug administration procedures.
Action Required
Review Newsletter Vol. 2, No. 23 from the provided URL to understand specific DESI drug product requirements and determine if any currently billed medications are affected. Monitor for any changes to drug coverage or prior authorization requirements for DESI-related products.